BioCentury
ARTICLE | Clinical News

Helixate FS regulatory update

October 17, 2005 7:00 AM UTC

CSL subsidiary ZLB Behring received FDA approval to store Helixate FS at room temperature for 3 months. Previously, the recombinant non-plasma derived Factor VIII to treat hemophilia A required refrig...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article